Success Metrics

Active Trials
0(0%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Other(2)

Detailed Status

unknown2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A

Trials by Status

unknown2100%

Recent Activity

0 active trials
Showing 2 of 2
unknown

Characteristics of LKDS and PBSS of KOA Based on the Enhancement of Inflammatory Response by TGF-β/Smad Pathway Inhibited

NCT05218122
unknown

PDR and SKYD of Dyslipidemia's Characteristics From the Oxidative Stress Enhancement Caused by Inhibition of Serine Metabolic Pathway

NCT04909489

Clinical Trials (2)

Showing 2 of 2 trials
NCT05218122

Characteristics of LKDS and PBSS of KOA Based on the Enhancement of Inflammatory Response by TGF-β/Smad Pathway Inhibited

Unknown
NCT04909489

PDR and SKYD of Dyslipidemia's Characteristics From the Oxidative Stress Enhancement Caused by Inhibition of Serine Metabolic Pathway

Unknown

All 2 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
2